Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium

Volkan Hurmeric,1 Pravin Vaddavalli,1 Anat Galor,1,2 Victor L Perez,1 Janika San Roman,1 Sonia H Yoo11Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Miami Veterans Affairs Medical Center, Miami, FL, USAPurpose: To assess the effect of single versus mult...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hurmeric V, Vaddavalli P, Galor A, Perez VL, San Roman J, Yoo SH
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/77c67ce45ba74c72a9bd613dd00790c3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:77c67ce45ba74c72a9bd613dd00790c3
record_format	dspace
spelling	oai:doaj.org-article:77c67ce45ba74c72a9bd613dd00790c32021-12-02T02:58:44ZSingle and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium1177-54671177-5483https://doaj.org/article/77c67ce45ba74c72a9bd613dd00790c32013-03-01T00:00:00Zhttp://www.dovepress.com/single-and-multiple-injections-of-subconjunctival-ranibizumab-for-earl-a12368https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Volkan Hurmeric,1 Pravin Vaddavalli,1 Anat Galor,1,2 Victor L Perez,1 Janika San Roman,1 Sonia H Yoo11Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Miami Veterans Affairs Medical Center, Miami, FL, USAPurpose: To assess the effect of single versus multiple subconjunctival ranibizumab injections in patients with an early pterygium recurrence.Setting: Single-center, academic practice.Study population: Nine patients with early pterygium recurrence.Observational procedure: Subconjunctival ranibizumab (0.5 mg/0.05 mL) was administered adjacent to pterygium recurrence. Group 1 (n = 5) received one injection; group 2 (n = 4) received three injections (time points 0, 2, and 4 weeks) with the ability to retreat as needed.Main outcome measures: Effect of ranibizumab on conjunctival hyperemia and corneal neovascular area over a 6-month follow-up period.Results: In the single injection group, a decrease in conjunctival hyperemia was noted in all patients on postinjection day 1. At follow up, hyperemia grade fluctuated, although all patients had less hyperemia than at baseline. In the recurrent injection group, the median number of injections was 8.5 (range 7 to 9) over the 6 months. In spite of the repeated injections, the pattern of conjunctival hyperemia was similar to that of the single injection group. In group 1, corneal neovascularization remained relatively unchanged over the 6-month period in four patients and decreased in one patient by 24%. In group 2, corneal neovascularization increased in one patient by 39%, remained stable in one patient, and decreased in two patients by 34% and 44%.Conclusion: This is the first study to evaluate the role of ranibizumab in the treatment of an early pterygium recurrence and the first to compare multiple versus single injections. Recurrent injections did not appear to be superior to a single injection with regards to conjunctival hyperemia.Keywords: pterygium, recurrence, ranibizumab, conjunctival hyperemia, corneal neovascularizationHurmeric VVaddavalli PGalor APerez VLSan Roman JYoo SHDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 467-473 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Hurmeric V Vaddavalli P Galor A Perez VL San Roman J Yoo SH Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
description	Volkan Hurmeric,1 Pravin Vaddavalli,1 Anat Galor,1,2 Victor L Perez,1 Janika San Roman,1 Sonia H Yoo11Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Miami Veterans Affairs Medical Center, Miami, FL, USAPurpose: To assess the effect of single versus multiple subconjunctival ranibizumab injections in patients with an early pterygium recurrence.Setting: Single-center, academic practice.Study population: Nine patients with early pterygium recurrence.Observational procedure: Subconjunctival ranibizumab (0.5 mg/0.05 mL) was administered adjacent to pterygium recurrence. Group 1 (n = 5) received one injection; group 2 (n = 4) received three injections (time points 0, 2, and 4 weeks) with the ability to retreat as needed.Main outcome measures: Effect of ranibizumab on conjunctival hyperemia and corneal neovascular area over a 6-month follow-up period.Results: In the single injection group, a decrease in conjunctival hyperemia was noted in all patients on postinjection day 1. At follow up, hyperemia grade fluctuated, although all patients had less hyperemia than at baseline. In the recurrent injection group, the median number of injections was 8.5 (range 7 to 9) over the 6 months. In spite of the repeated injections, the pattern of conjunctival hyperemia was similar to that of the single injection group. In group 1, corneal neovascularization remained relatively unchanged over the 6-month period in four patients and decreased in one patient by 24%. In group 2, corneal neovascularization increased in one patient by 39%, remained stable in one patient, and decreased in two patients by 34% and 44%.Conclusion: This is the first study to evaluate the role of ranibizumab in the treatment of an early pterygium recurrence and the first to compare multiple versus single injections. Recurrent injections did not appear to be superior to a single injection with regards to conjunctival hyperemia.Keywords: pterygium, recurrence, ranibizumab, conjunctival hyperemia, corneal neovascularization
format	article
author	Hurmeric V Vaddavalli P Galor A Perez VL San Roman J Yoo SH
author_facet	Hurmeric V Vaddavalli P Galor A Perez VL San Roman J Yoo SH
author_sort	Hurmeric V
title	Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
title_short	Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
title_full	Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
title_fullStr	Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
title_full_unstemmed	Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
title_sort	single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/77c67ce45ba74c72a9bd613dd00790c3
work_keys_str_mv	AT hurmericv singleandmultipleinjectionsofsubconjunctivalranibizumabforearlyrecurrentpterygium AT vaddavallip singleandmultipleinjectionsofsubconjunctivalranibizumabforearlyrecurrentpterygium AT galora singleandmultipleinjectionsofsubconjunctivalranibizumabforearlyrecurrentpterygium AT perezvl singleandmultipleinjectionsofsubconjunctivalranibizumabforearlyrecurrentpterygium AT sanromanj singleandmultipleinjectionsofsubconjunctivalranibizumabforearlyrecurrentpterygium AT yoosh singleandmultipleinjectionsofsubconjunctivalranibizumabforearlyrecurrentpterygium
_version_	1718402048821559296

Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium

Ejemplares similares